Matthijs Oyaert

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection

Jan Van Elslande, Matthijs Oyaert, Scott Ailliet et al. · Journal of Clinical Virology · 2021 · 155 citations · Full text

Viral Persistence, Longitudinal Follow-up, Viral Pathogenesis +4

Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection

Jan Van Elslande, Matthijs Oyaert, Natalie Lorent et al. · Diagnostic Microbiology and Infectious Disease · 2022 · 96 citations · Full text

Vaccination, Viral Persistence, Sars-cov-2 Infection +9

Novel LC–MS/MS method for plasma vancomycin: Comparison with immunoassays and clinical impact

Matthijs Oyaert, Nele Peersman, Davy Kieffer et al. · Clinica Chimica Acta · 2014 · 87 citations · Full text

Plasma Vancomycin, Medicine, Novel Lc–ms/ms Method +6

Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease

Matthijs Oyaert, An Boel, J W Jacobs et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2017 · 58 citations · Full text

Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients

Matthijs Oyaert, Marie‐Angélique De Scheerder, Sophie Van Herrewege et al. · Frontiers in Immunology · 2022 · 58 citations · Full text